feed,title,long_url,short_url
r/ScientificNutrition,[Randomized Controlled Trial] Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial,https://redd.it/mho59z,
